BridgeBio Pharma, Inc. 4 filing

Filed 2026-03-03 · Report date 2026-02-27 · 2026

View Original SEC Filing

Filing metadata

Accession number: 0001470831-26-000236
Form type: 4
CIK: 0001743881
Primary document: https://www.sec.gov/Archives/edgar/data/1743881/000147083126000236/xslF345X05/wk-form4_1772572630.xml

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for BridgeBio Pharma, Inc..

Reported financial metrics

Metric	Current	Prior	Change